Highlights
- •A considerable number of PWE experienced more symptoms of existing health conditions and fear of seizure during the initial year of the pandemic (2020).
- •Fear of seeking healthcare services was associated with both negative outcomes.
- •Assuring access to health care and reducing social isolation could potentially reduce negative outcomes for PWE.
- •The fear of seeking healthcare during COVID-19 was associated with both exacerbated co-occurring health conditions and increasing fear of seizure.
- •Social isolation was associated with exacerbated co-occurring health conditions during COVID-19.
- •Reduced access to physical healthcare was associated with increasing fear of seizures.
Abstract
Objective
Methods
Results
Conclusion
Keywords
1. Introduction
Underlying medical conditions associated with higher risk for severe COVID-19: Information for Healthcare professionals [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; [cited 2022Dec6]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html.
Underlying medical conditions associated with higher risk for severe COVID-19: Information for Healthcare professionals [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; [cited 2022Dec6]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html.

2. Methods
2.1 Study design
2.2 Participants
- We accepted one response from each IP address and excluded responses with a duplicate IP address (n = 7).
- Short survey completion times (less than 7 min) were considered improbably fast responses and were excluded (n = 11).
2.3 Measurements
2.3.1 Increasing symptoms for health conditions, and fear of seizure during the pandemic.
- 1-Symptoms of pre-existing or current health conditions
- 2-Fear of having a seizure”
2.3.2 COVID-19 stressors
2.3.3 Demographic and medical history.
2.4 Statistical analysis
3. Results
3.1 Participant characteristics
Variable | N (%), Mean ± SD | |
---|---|---|
Medical demographic | ||
Age (mean ± SD) | 38.7 ± 14.8 | |
Gender | Women | 165(63.5) |
Men | 95(36.5) | |
Race | White | 185 (71.2) |
Black | 21 (8.1) | |
Hispanic | 36 (13.8) | |
Other | 18 (7.0) | |
Education | Less than High School | 16 (6.2) |
High School | 68 (26.2) | |
Some College | 69 (26.5) | |
More than College | 107 (41.2) | |
Diagnosed with COVID-19 | Yes | 19 (7.3) |
No | 241 (92.7) | |
Seizure Severity* (mean ± SD) | 3.16 ± 1.55 | |
Seizure Control | Seizure free ≥ 1 year | 91 (35.0) |
Seizure within 1 year | 169 (65.0) |
3.2 Stressors during COVID-19
3.3 Changes in health condition and fear of seizure during COVID-19
PWE with Stable or Decreased Symptoms of Co-Occurring Health Conditions | PWE with exacerbated co-occurring health conditions | p-value | |
---|---|---|---|
N = 181 | N = 79 | ||
Stress | <0.001 | ||
No Change or Decreased | 53.00% | 15.20% | |
Increased | 47.00% | 84.80% | |
Anxiety | <0.001 | ||
No Change or Decreased | 54.70% | 16.50% | |
Increased | 45.30% | 83.50% | |
Social Isolation | <0.001 | ||
No Change or Decreased | 61.30% | 26.60% | |
Increased | 38.70% | 73.40% | |
Anger | <0.001 | ||
No Change or Decreased | 74.60% | 46.80% | |
Increased | 25.40% | 53.20% | |
Fear of Seeking Healthcare | <0.001 | ||
No Change or Decreased | 80.70% | 48.10% | |
Increased | 19.30% | 51.90% | |
Alcohol Consumption | 0.072 | ||
No Change or Decreased | 81.80% | 70.90% | |
Increased | 18.20% | 29.10% | |
Access of Physical Healthcare | <0.001 | ||
No Change or Increased | 78.50% | 46.80% | |
Decreased | 21.50% | 53.20% | |
Access to Mental Healthcare | <0.001 | ||
No Change or Increased | 72.90% | 45.60% | |
Decreased | 27.10% | 54.40% | |
Control Over Life | <0.001 | ||
No Change or Increased | 67.40% | 39.20% | |
Decreased | 32.60% | 60.80% | |
Age | 39.4 (15.7) | 37.1 (12.4) | 0.192 |
Gender | 0.133 | ||
Female | 60.20% | 70.90% | |
Male | 39.80% | 29.10% | |
Race | 0.352 | ||
White | 70.20% | 73.40% | |
Black | 9.94% | 3.80% | |
Hispanic | 12.70% | 16.50% | |
Mixed | 7.18% | 6.33% | |
Education | 0.756 | ||
High School | 24.30% | 30.40% | |
Less than High School | 6.63% | 5.06% | |
More than College | 41.40% | 40.50% | |
Some College | 27.60% | 24.10% | |
Diagnosed with COVID-19 | 0.706 | ||
Yes | 6.63% | 8.86% | |
Seizure Severity* | 3.02 (1.51) | 3.48 (1.61) | 0.033 |
Seizure-free in the past year | <0.001 | ||
No | 57.50% | 82.30% | |
Yes | 42.50% | 17.70% |
PWE without Change in Fear of Seizure | PWE with Increased Fear of Seizure | p-value | |
---|---|---|---|
N = 166 | N = 94 | ||
Stress | <0.001 | ||
No Change or Decreased | 53.00% | 21.30% | |
Increased | 47.00% | 78.70% | |
Anxiety | <0.001 | ||
No Change or Decreased | 54.20% | 23.40% | |
Increased | 45.80% | 76.60% | |
Social Isolation | <0.001 | ||
No Change or Decreased | 59.60% | 35.10% | |
Increased | 40.40% | 64.90% | |
Anger | 0.018 | ||
No Change or Decreased | 71.70% | 56.40% | |
Increased | 28.30% | 43.60% | |
Fear of Seeking Healthcare | <0.001 | ||
No Change or Decreased | 82.50% | 50.00% | |
Increased | 17.50% | 50.00% | |
Alcohol Consumption | 0.099 | ||
No Change or Decreased | 81.90% | 72.30% | |
Increased | 18.10% | 27.70% | |
Access of Physical Healthcare | <0.001 | ||
No Change or Increased | 80.10% | 48.90% | |
Decreased | 19.90% | 51.10% | |
Access of Mental Healthcare | 0.002 | ||
No Change or Increased | 71.70% | 52.10% | |
Decreased | 28.30% | 47.90% | |
Control Over Life | 0.002 | ||
No Change or Increased | 66.30% | 45.70% | |
Decreased | 33.70% | 54.30% | |
Age | 39.3 (16.1) | 37.6 (12.1) | 0.333 |
Gender | 0.967 | ||
Female | 63.90% | 62.80% | |
Male | 36.10% | 37.20% | |
Race | 0.071 | ||
White | 74.70% | 64.90% | |
Black | 4.82% | 13.80% | |
Hispanic | 13.30% | 14.90% | |
Mixed | 7.23% | 6.38% | |
Education | 0.288 | ||
High School | 29.50% | 20.20% | |
Less than High School | 6.63% | 5.32% | |
More than College | 37.30% | 47.90% | |
Some College | 26.50% | 26.60% | |
Diagnosed by COVID-19 | 0.855 | ||
You | 7.83% | 6.38% | |
Seizure Severity* | 2.78 (1.49) | 3.83 (1.44) | <0.001 |
Freedom of Seizure | <0.001 | ||
No | 54.20% | 84.00% | |
Yes | 45.80% | 16.00% |
3.4 Multivariate analysis


4. Discussion
5. Study limitations
6. Conclusion
Acknowledgements
References
- Clinical characteristics of coronavirus disease 2019 in China.N Engl J Med. 2020; 382: 1708-1720
Underlying medical conditions associated with higher risk for severe COVID-19: Information for Healthcare professionals [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; [cited 2022Dec6]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html.
- COVID-19 among patients with epilepsy: risk factors and course of the disease.Epilepsy Behav. 2021; 1107996
- Looking forward to a decade of the biopsychosocial model.BJ Psych Bull. 2022; 46: 228-232
- The biopsychosocial model and quality of life in persons with active epilepsy.Epilepsy Behav. 2014; 1: 55-65
- COVID-19 pandemic in Istanbul: Seizure frequency and psychosocial outcomes in patients with epilepsy.Neurol Asia. 2022; 27
- Considering temporality in causal relationship between seizure worsening and psychological stress in patients with epilepsy during the COVID-19 pandemic: A systematic review.Epilepsy Behav. 2021; 1108184
- Correlation of seizure increase and COVID-19 outbreak in adult patients with epilepsy: findings and suggestions from a nationwide multi-centre survey in China.Seizure. 2021; 1: 102-108
- Severe psychological distress among patients with epilepsy during the COVID-19 outbreak in southwest China.Epilepsia. 2020; 61: 1166-1173
- Emergency implementation of telemedicine for epilepsy in Spain: results of a survey during SARS-CoV-2 pandemic.Epilepsy Behav. 2020; 1107211
- Impacts of the COVID-19 pandemic on Iranian patients with epilepsy.Acta Neurol Scand. 2020; 142: 392-395
- Covid-19 and health care’s digital revolution.N Engl J Med. 2020; 382: e82
- Keeping people with epilepsy safe during the COVID-19 pandemic.Neurology. 2020; 94: 1032-1037
- Prevalence of depression, anxiety, and psychological distress in patients with epilepsy during COVID-19: A systematic review.Epilepsy Behav. 2021; 1108410
- Comorbidities of epilepsy: current concepts and future perspectives.Lancet Neurol. 2016; 15: 106-115
- Hypertension, seizures, and epilepsy: a review on pathophysiology and management.Neurol Sci. 2019; 40: 1775-1783
- Depression in epilepsy: a systematic review and meta-analysis.Neurology. 2013; 80: 590-599
- Seizure phobia: A distinct psychiatric disorder among people with epilepsy.Seizure. 2022; 1: 26-32
- Daily life in epilepsy: patients’ experiences described by emotions.Epilepsy Behav. 2007; 10: 389-396
- The psychological impact of quarantine and how to reduce it: rapid review of the evidence.Lancet. 2020; 395: 912-920
- Social consequences of mass quarantine during epidemics: a systematic review with implications for the COVID-19 response.J Travel Med. 2020; 27: taaa192
- Anger is a distinctive feature of epilepsy patients with depression.Tohoku J Exp Med. 2014; 232: 123-128
- The relationship between epilepsy and anxiety disorders.Curr Psychiatry Rep. 2019; 21: 1-3
- Stress and epilepsy: fact or fiction, and what can we do about it?.Pract Neurol. 2016; 16: 270-278
- Systematic review of unmet healthcare needs in patients with epilepsy.Epilepsy Behav. 2017; 1: 102-109
- Pathways and access to mental health care services by persons living with severe mental disorders and epilepsy in Uganda, Liberia and Nepal: a qualitative study.BMC Psychiatry. 2016; 16: 1
- Depression, sleep quality, and social isolation among people with epilepsy in Bhutan: A cross-sectional study.Epilepsy Behav. 2020; 112: 107450
- Self-management in epilepsy: Why and how you should incorporate self-management in your practice.Epilepsy Behav. 2017; 1: 220-224
- Alcohol use and alcohol-related seizures in patients with epilepsy.Front Neurol. 2018; 5: 401
- Global assessment of the severity of epilepsy (GASE) Scale in children: Validity, reliability, responsiveness.Epilepsia. 2015; 56: 1950-1956
- Determinants of disease severity in adults with epilepsy: results from the neurological diseases and depression study.Epilepsy Behav. 2015; 1: 170-175
- The personal impact of epilepsy scale (PIES).Epilepsy Behav. 2015; 1: 140-146
- Epilepsy in the time of COVID-19.Acta Neurol Scand. 2021;
- Patients with epilepsy during the COVID-19 pandemic: Depressive symptoms and their association with healthcare access.Epilepsy Behav. 2021; 1108178
- Epilepsy care during the COVID-19 pandemic.Epilepsia. 2021; 62: 2322-2332
- Delays in stroke onset to hospital arrival time during COVID-19.Stroke. 2020; 51: 2228-2231
- Characteristics and hospital course of patients admitted for acute cardiovascular diseases during the coronavirus disease-19 outbreak.J Cardiovasc Med. 2021; 22: 29-35
- Telemedicine in epilepsy management during the coronavirus disease 2019 pandemic.Pediatr Int. 2022; 64: e14972
- Telemedicine and the challenge of epilepsy management at the time of COVID-19 pandemic.Epilepsy Behav. 2020; 1: 110
- Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity.BMC Infect Dis. 2021; 21: 1
- Disparities in the population at risk of severe illness from COVID-19 by race/ethnicity and income.Am J Prev Med. 2020; 59: 137-139
- Characteristics, comorbidities, and data gaps for coronavirus disease deaths, Tennessee, USA.Emerg Infect Dis. 2021; 27: 2521
- Racial/ethnic and income disparities in the prevalence of comorbidities that are associated with risk for severe COVID-19 among adults receiving HIV care, United States, 2014–2019.J Acquir Immune Defic Syndr (1999). 2021; 86
- Seizure control, stress, and access to care during the COVID-19 pandemic in New York City: The patient perspective.Epilepsia. 2021; 62: 41-50
- Recalling the COVID-19 lockdown: Insights from patients with epilepsy.Epilepsy Behav. 2021; 1107573
- Impact of social isolation due to COVID-19 on health in older people: mental and physical effects and recommendations.J Nutr Health Aging. 2020; 24: 938-947
- Preliminary findings on the associations between mental health indicators and social isolation during the COVID-19 pandemic.Arch Psychiatry Psychother. 2020; 22: 10-19
- Social relationships and depression during the COVID-19 lockdown: longitudinal analysis of the COVID-19 Social Study.Psychol Med. 2021; 13
- Amygdala reactivity and mood-congruent memory in individuals at risk for depressive relapse.Biol Psychiatry. 2007; 61: 231-239
- Socio-economic impact on epilepsy outside of the nation-wide COVID-19 pandemic area.Epilepsy Behav. 2021; 1107886
- The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy.Epilepsy Behav. 2020; 1107323
- Prevalence and risk factors of depression and anxiety among patients with convulsive epilepsy in rural West China.Acta Neurol Scand. 2018; 138: 541-547
- CoVID-19 vs. epilepsy: It is time to move, act, and encourage physical exercise.Epilepsy Behav. 2020; : 110
- Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: A multicountry online survey.Epilepsy Behav. 2020; 1107350
- Epilepsy self-management during a pandemic: experiences of people with epilepsy.Epilepsy Behav. 2020; 1107238
- The impact of first and second wave of the COVID-19 pandemic in society: comparative analysis to support control measures to cope with negative effects of future infectious diseases.Environ Res. 2021; 1111099
- Influence of COVID-19 pandemic on quality of life in patients with epilepsy–Follow-up study.Epilepsy Behav. 2021; 1108026